Patna: Medical experts have raised concerns over the declining effectiveness of several conventional drugs used to treat leprosy, warning that evolving disease patterns and possible resistance are complicating treatment outcomes. The issue was discussed at a scientific and academic programme organised by the Bihar chapter of the Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) ahead of World Leprosy Day on January, 30.
The day-long session brought together dermatologists, clinicians and researchers to review changes in the epidemiology of leprosy, assess existing treatment protocols and explore newer therapeutic options. Specialists stressed that while the disease is curable, delayed diagnosis and outdated medication strategies could lead to preventable deformities, disabilities and long-term social stigma for patients.
Dr Swetalina Pradhan, head of department at AIIMS Patna, said that several traditional anti-leprosy drugs are gradually losing their clinical effectiveness. She emphasised the need to introduce newer medications and reassess multidrug therapy to ensure better outcomes. “The reduced efficacy of conventional treatment demands innovative pharmaceutical approaches and updated strategies,” she said.
Speakers also highlighted the importance of timely intervention. Dr Ramavatar Singh, who chaired the session, noted that early detection and appropriate therapy can significantly reduce complications and disability. National vice-president Dr Abhishek Kumar Jha added that greater awareness and prompt care could help bring the disease under control, saying leprosy today is both preventable and curable when managed correctly.
The programme featured discussions on complex and challenging cases led by Dr M.D. Mobarak, with panelists sharing practical solutions for real-world clinical settings. Other experts addressed the broader medical and social impact of the disease, including its effects on children and the role of immunological factors in progression and recovery.
As part of outreach efforts, the association will organise an awareness march near Gandhi Maidan on January, 25. Senior dermatologists and healthcare professionals are expected to participate, aiming to educate the public and combat the stigma that continues to surround one of India’s oldest yet still misunderstood diseases.
